Oncogenic transformation produced by agents and modalities used in cancer therapy and its modulation.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000209:etiology*; D006224:Cricetinae; D004622:Embryo, Mammalian; D005720:Gamma Rays; D051379:Mice; D009374:Neoplasms, Experimental / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D013482:Superoxide Dismutase / Q000494:pharmacology; D014212:Tretinoin / Q000031:analogs & derivatives / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology; D014965:X-Rays
D000970:Antineoplastic Agents; D014284:Triiodothyronine; C009675:vitamin A acid ethylamide; D014212:Tretinoin; D013482:Superoxide Dismutase